Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Encompass Health Corporation
EHC
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $10.1B
$105.76
▲ +4.31%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$92.77 - $127.99
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 14.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Largest operator of inpatient rehabilitation hospitals in the United States with scale and operational expertise
- Diversified revenue streams across inpatient, home health, and hospice services reducing market risk
- Established relationships with hospital systems and payers built over decades of operations
- Geographic footprint and infrastructure advantage in high-population markets, particularly the Southeast and Texas
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging Baby Boomer population driving increased demand for post-acute rehabilitation services
Value
Attractively priced below Healthcare Facilities peer average
Momentum
Stable
+4.1% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
0.75% yield
Smart-money signal
Who's buying EHC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 3, 2026
APR 30, 2026
Reported EPS of $1.60 vs $1.51 consensus (+6.0% surprise). Revenue of $1.6B vs $1.6B expected (+1.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+6.0%
Next: Aug 3, 2026
Revenue trend · last 8Q
—
—
—
—
+12%
+9%
+10%
+9%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$1.3B
$1.4B
$1.4B
$1.5B
$1.5B
$1.5B
$1.5B
$1.6B
Margins · last 8Q
Gross
48.4%
Operating
19.0%
Profit
12.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$146.00
▲ +38.0% vs $105.76
Latest: Leerink · $152.00 · May 22, 2026
2 analysts covering